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Abstract
Background: Chronic fatigue syndrome (CFS) is a debilitating illness with no known cause or
effective therapy. Population-based epidemiologic data on CFS prevalence are critical to put CFS in
a realistic context for public health officials and others responsible for allocating resources.
Methods: We conducted a pilot random-digit-dialing survey to estimate the prevalence of fatiguing
illnesses in different geographic regions and in urban and rural populations of the United States.
This report focuses on 884 of 7,317 respondents 18 to 69 years old. Fatigued (440) and randomly
selected non-fatigued (444) respondents completed telephone questionnaires concerning fatigue,
other symptoms, and medical history.
Results: We estimated 12,186 per 100,000 persons 18 to 69 years of age suffered from fatigue
lasting for at least 6 months (chronic fatigue), and 1,197 per 100,000 described an illness that,
though lacking clinical evaluation, met criteria for CFS (CFS-like). Chronic fatigue and CFS-like
illness were more common in rural than in urban populations, although the differences were not
significant. The prevalence of these fatiguing illnesses did not differ meaningfully among the four
regions surveyed, and no significant geographic trends were observed.
Conclusions: This investigation estimated that nearly 2.2 million American adults suffer from CFS-
like illness. The study also suggested the need to focus future investigations of fatigue on
populations with lower incomes and less education. There was no evidence for regional differences
in the occurrence of fatiguing illnesses.
Background
An understanding of the national prevalence and distribu-
tion of chronic fatigue syndrome (CFS) is fundamental to
focusing etiologic research, targeting health-care and edu-
cational programs, and estimating the secondary effects of
debilitating fatigue on quality of life and on productivity.
By ranking the burden of CFS and fatiguing illnesses
among other national health concerns, a prevalence
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estimate can help frame appropriate health policy and
raise political and public awareness for the concerns that
emanate from this misunderstood and highly stigmatized
syndrome.
Only two studies have examined population-based, ran-
dom samples to estimate the prevalence of CFS and
describe its demographic and socioeconomic characteris-
tics. These studies surveyed the populations of Wichita,
Kansas, and Chicago, Illinois, and determined similar
estimates of CFS prevalence (142–560 per 100,000 per-
sons) in the two cities [1,2]. In both studies, CFS primarily
affected women, but the distribution of CFS by other
descriptive characteristics differed between the two cities.
These differences may reflect geographic and urbanization
characteristics specific to the Wichita and Chicago metro-
politan areas.
A national survey of CFS would be necessary to resolve
questions raised by these two studies and to obtain infor-
mation that could be generalized to CFS in the United
States. Objectives of a national survey would include esti-
mating the prevalence of CFS in urban and rural popula-
tions in different regions of the country; examining
relationships between CFS and sex, age, race/ethnicity,
and socioeconomic status in the different settings; and,
exploring relationships among these variables and
national patterns of health care use. Between July 2001
and January 2002, we conducted a pilot survey to deter-
mine feasibility and to test procedures for a national sur-
vey of CFS. The pilot study showed that clinical evaluation
of persons with fatigue and accompanying symptoms
characteristic of CFS (CFS-like illness) on a national level
was logistically impractical and raised numerous issues of
standardization and quality control. We elected not to
pursue the full national survey. Nonetheless, the pilot sur-
vey collected important information concerning the epi-
demiology of chronic fatigue and CFS-like illness in a
random sample of people selected from eight strata that
comprised the contiguous United States.
Methods
This study adhered to human experimentation guidelines
of the U.S. Department of Health and Human Services
and complies with the Helsinki Declaration. All partici-
pants were volunteers who gave informed consent.
Study design
The survey used a stratified two-stage cluster design simi-
lar to that described in our previous study of fatiguing ill-
nesses in the general population of Wichita, Kansas [1].
Briefly, the first stage of sampling selected a primary sam-
pling unit (PSU) in each stratum, and the second stage
drew a sample of telephone numbers for each PSU. Phase
I of data collection screened households for individuals
identified as fatigued for ≥ 1 month. Phase II comprised
detailed telephone interviews with individuals identified
as fatigued and with a random sample of persons identi-
fied as non-fatigued. Phase III was a clinical evaluation of
chronically fatigued subjects who, based on telephone
interviews, had no exclusionary medical or psychiatric
conditions and who met fatigue and symptom criteria of
CFS (CFS-like).
Sampling strategy
To examine regional and metropolitan differences, we
constructed strata from statistical areas defined by the US
Census. Each of the four US Census regions (Northeast,
Midwest, South, and West) was further stratified into met-
ropolitan statistical areas (MSAs) and non-MSA counties.
The U.S. Office of Management and Budget defines sev-
eral categories of MSA, according to specific standards. In
general terms an MSA has a core area containing a sizable
population, together with adjacent communities that
have a high degree of economic and social integration
with that core. From each of the eight strata, we randomly
selected a primary sampling unit (PSU), either an MSA or
a non-MSA county (as appropriate). Because only one
PSU was selected from each stratum, the results do not
provide estimates of within-stratum variability. The eight
PSUs selected were Buffalo-Niagara Falls, New York
(Northeast urban), Chicago, Illinois (Midwest urban),
Baton Rouge, Louisiana (South urban), Oakland, Califor-
nia (West urban), Franklin County, Pennsylvania (North-
east rural), Ripley County, Indiana (Midwest rural),
Monroe County, Georgia (South rural), and Chaves
County, New Mexico (West rural). For each PSU, 1,800
telephone numbers were randomly selected using the
GENESYS Sampling System (Marketing Systems Group,
Fort Washington, PA) and identifiable non-working and
business numbers were removed. Advance letters, explain-
ing the study, were sent to all households whose tele-
phone number could be matched to a mailing address.
Phase I – telephone screening interviews
In each selected household, we screened an adult house-
hold informant who was at least 18 years old. The nature
of the study was explained to the informant, who was
requested to consent verbally before proceeding with the
interview. The informant enumerated individual house-
hold members and reported on their age, sex, race, and
fatigue status. Informants were asked whether any house-
hold members were currently suffering from severe
fatigue, extreme tiredness, or exhaustion that had lasted 1
month or longer.
Phase II – detailed telephone interviews
Household residents older than 18 years identified with
fatigue ≥ 1 month were contacted for detailed interviews;
parents were interviewed on behalf of adolescents (12 toPopulation Health Metrics 2004, 2 http://www.pophealthmetrics.com/content/2/1/1
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17 years old). We also conducted detailed interviews on a
random sample of non-fatigued adults 18 to 69 years old
selected in a two-step process. First, households were ran-
domly selected (with a probability of 0.25) to supply a
non-fatigued person for a detailed interview. Second, if
the household enumeration identified at least one age-eli-
gible non-fatigued person in the household, a non-
fatigued person was selected at random. Only one non-
fatigued person could be selected from a household. A
household in which a fatigued person was selected was
eligible to have a non-fatigued person selected as well.
However, in this study no household had both a fatigued
and non-fatigued resident selected for interview.
As with the screening interview, the nature of the study
was explained and subjects provided verbal informed con-
sent before proceeding with the interview. The detailed
interview included questions on fatigue (characteristics
and duration), symptoms (occurrence, nature, and dura-
tion), demographics, and medical/psychiatric history. It
also included the 12-item Short Form Health Survey®
(QualityMetric, Inc., Lincoln, RI), which is designed to
measure health-related quality of life.
Case definitions
CFS is an illness defined by symptoms and associated dis-
ability and by excluding medical diseases or psychiatric
conditions that could explain them. There are no confirm-
atory physical signs or characteristic laboratory abnormal-
ities. The current international CFS case definition [3]
defines CFS as clinically evaluated, medically or psychiat-
rically unexplained, persistent or relapsing fatigue of at
least 6 months duration that is not the result of ongoing
exertion, is not substantially alleviated by rest, and results
in substantial reduction in previous levels of occupa-
tional, educational, social, or personal activities. The
fatigue must be accompanied by at least 4 of 8 symptoms
that must have persisted or recurred during at least 6 con-
secutive months and cannot have predated the fatigue.
Case defining symptoms include: 1) unusual post-exer-
tional malaise of more than a day's duration following
previously tolerated levels of mental or physical exertion;
2) unrefreshing sleep; 3) impaired short-term memory or
concentration with substantial reduction in occupational,
educational, social, or personal activities; 4) headaches of
a new type, pattern, or severity; 5) muscle pain; 6) multi-
joint pain without swelling or redness; 7) sore throat; 8)
tender cervical/axillary lymph nodes. The current CFS case
definition relies entirely on self-reported symptoms and
disability and specifies no standard measures. Recently an
International Chronic Fatigue Syndrome Study Group has
recommended resolutions for the major ambiguities [4].
This study relied on telephone interview to classify sub-
jects. We used the CDC detailed telephone interview ques-
tionnaire to identify and characterize fatigue,
accompanying symptoms, and exclusionary conditions.
This questionnaire (available from the authors on
request) included minor modifications of one used over 4
years of surveillance in Wichita [1]. Individuals reporting
fatigue lasting at least 6 months were classified as having
chronic fatigue. We classified chronically fatigued
respondents as having a CFS-likeillness if they had no
medical or psychiatric exclusions identified during the
interview and reported chronic fatigue that was not allevi-
ated by rest and was accompanied at least 4 of the 8 CFS
defining symptoms. Whether fatigue substantially inter-
fered with work, educational, or personal activities was
not assessed in the detailed telephone interviews. Classifi-
cation as CFSrequires a complete physical examination to
accurately detect medical or psychiatric conditions that
subjects may not recount on interview. Fatigue categories
were analyzed as discrete groups (chronic fatigueand CFS-
like), and each subject was counted only in the most
restrictive category that applied.
Statistical analyses
Prevalence estimates were based on weighted data. Each
household received a base sampling weight that reflected
the probability of selection of the PSU and selection of the
household telephone number within the PSU. The final
household sampling weight incorporated adjustments for
multiple residential lines, non-response, and households
without telephones. For non-fatigued individuals who
completed detailed interviews, the person-level weight
was determined by the household weight and the person's
probability of selection. For fatigued individuals, all of
whom were selected with certainty, the person-level
weight for the detailed interview equaled the household
weight. Weighted prevalences and weighted Pearson chi-
squared and Wald statistics were calculated by using
STATA 7.0 (Stata Corporation, College Station, TX). Con-
fidence intervals for prevalences were constructed by
using a logit transformation (hence the lower endpoint
was always greater than 0).
Results
Interview sample
Of the 14,405 telephone numbers in the sample, 7,573
(52.6%) were ineligible because they belonged to busi-
nesses, were not working, or were cellular phones. Resi-
dential status could not be determined for 4,018 (27.9%)
of the numbers: 791 (5.5%) because all attempts pro-
duced no contact (i.e., the number was busy, was tempo-
rarily disconnected, or rang but was never answered), 278
(1.9%) because the attempts reached only an answering
machine, and 2,949 (20.5%) because of some other out-
come (mainly the person answering refused to participate
before household status could be determined). The
remaining 2,809 (19.5%) numbers were residential, andPopulation Health Metrics 2004, 2 http://www.pophealthmetrics.com/content/2/1/1
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2,728 (97.1%) of these households completed screening
interviews. These 2,728 households contained a total of
7,317 individuals; 744 had fatigue lasting ≥ 1 month, and
6,573 were non-fatigued.
Eighty-four of the 744 individuals identified as fatigued
were ineligible for the detailed interview (outside age
range, language barrier) and 161 (21.6%) refused to par-
ticipate. The remaining 455 persons identified as fatigued
in the screening interview completed detailed interviews;
440 were between the ages of 18 and 69 and are included
in this report. Six hundred of the 6,573 non-fatigued indi-
viduals were selected for a detailed interview; 444 non-
fatigued individuals between the ages of 18 and 69 com-
pleted detailed interviews and are included in this report.
Eligibility and refusal rates were similar for non-fatigued
and fatigued respondents.
The 884 respondents completing detailed interviews rep-
resent a weighted population of 181,000,000 persons in
the eight strata; the 444 non-fatigued respondents repre-
sent 153,000,000 non-fatigued persons in the survey pop-
ulation. Of the 440 fatigued respondents, 53 reported
fatigue of less than 6 months duration, 338 were classified
as having chronic fatigue, and 49 satisfied the criteria for
CFS-like illness, representing an estimated 22 million and
2.2 million persons, respectively.
Population characteristics
Table 1 shows the weighted population characteristics by
fatigue category estimated from the interview sample.
Demographics were similar to those reported by the US
2000 Census, except that the current study surveyed a
higher proportion of white non-Hispanic individuals. The
survey population was predominantly white (82%) and
non-Hispanic (95%). The mean age of respondents was
42 years, 37% reported an income of ≤ $40,000 per year,
and 57% reported education beyond high school.
As seen in Table 1, the distributions of sex, race, and eth-
nicity did not differ significantly among categories of
fatiguing illness. The proportion of individuals reporting
a household income of ≤ $40,000 or education beyond
high school was significantly different among fatigue cat-
egories (P < .0001 and = .0001, respectively). In general,
lower income and less education were associated with
higher prevalence of fatiguing illness.
Table 2 lists the weighted proportions of medical and psy-
chiatric conditions identified in the detailed interviews. A
higher proportion of individuals in the fatigued sample
(43.3%) reported medical and psychiatric exclusions than
in the non-fatigued sample (11.2%)(P < .0001).
Prevalence estimates
Table 3 presents overall prevalence estimates of fatiguing
illnesses and estimates by urban, rural, and regional loca-
tion. Chronic fatigue affected 12,186 per 100,000 per-
sons; we estimate that 1,197 people per 100,000 persons
suffered from CFS-like illness. Both chronic fatigue and
CFS-like illness were more common in rural than in urban
populations, although the differences were not signifi-
cant. There were no significant differences in prevalence
estimates by geographic regions.
Table 4 gives prevalence estimates of fatiguing illnesses by
demographic characteristics. Although women had much
higher prevalence of chronic fatigue and CFS-like illness
than men, the differences between these estimates were
not significant. The prevalence of chronic fatigue in whites
was significantly higher than in non-white individuals (P
= .024). The prevalence of reported chronic fatigue was
Table 1: Weighted proportion of descriptive characteristics in mutually exclusive categories of fatiguing illness.
Characteristic % Non-fatigued n = 444 % Chronic fatigue n = 338 % CFS-like n = 49 % Total
Female 57 66 70 58
W h i t e 8 18 98 8 8 2
Non-Hispanic 95 92 99 95
Age Group (years)
1 8 – 2 9 2 21 11 8 2 1
3 0 – 3 9 2 11 51 9 2 0
4 0 – 4 9 3 03 32 7 3 0
5 0 – 5 9 1 72 42 4 1 8
6 0 – 6 9 1 01 81 3 1 1
Household income
≤ $40,000* 34 50 49 37
Educational level*
≤ High school graduate 39 61 58 43
* Distribution differs significantly among categories. Tested by design-based Pearson chi-squared test P < .001).Population Health Metrics 2004, 2 http://www.pophealthmetrics.com/content/2/1/1
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significantly higher in the 40 to 49 year (P = .03), 50 to 59
year (P = .006), and 60 to 69 year (P = .012) age groups
than in the 18 to 29 year age group.
Individuals with incomes of ≤ $40,000 per year were more
likely to report chronic fatigue and CFS-like illness than
respondents with higher incomes. The prevalence of
chronic fatigue (P = .015) was significantly higher in the
low-income category. The prevalences of chronic fatigue
and CFS-like illness were highest in individuals who
reported no more than a high school education; but the
only significant difference was in the prevalence of
chronic fatigue (P = .002).
Discussion
This population-based pilot survey of US households esti-
mates that 12,186 per 100,000 adults in the US suffer
severe chronic fatigue of > 6 months, and 1,197 have a
CFS-like illness. The prevalence of CFS-like illness was
similar to that in the Wichita population (1,607 per
100,000) [1], which used a similar sampling strategy and
virtually identical telephone interviews. Age distributions
of CFS-like illness were similar in both this and the
Wichita study, the highest risk occurring in the 40 to 59
year age range. Finally, women were 2.3 times more likely
than men to be identified with CFS-like illness in both
Wichita and this pilot survey. However, in this survey the
difference was not statistically significant, most likely
reflecting small sample size.
Table 2: Weighted proportion of medical and psychiatric exclusionary conditions in non-fatigued and fatigued samples.
Medical or Psychiatric Exclusionary Condition % Non-fatigued % Fatigued*
Any exclusionary condition 11.16 43.26
Rheumatoid arthritis 1.86 13.13
Lupus/Sjögren's syndrome 0.00 2.70
Pregnancy 6.48 7.66
Heart failure/fluid in lungs 1.95 6.35
Hepatitis/cirrhosis 0.41 4.20
Immunodeficiency disease 0.00 1.63
Multiple sclerosis 0.08 2.54
Heart condition limiting walking 0.16 5.52
Heart attack 1.70 3.66
Organ transplant 0.91 0.36
Stroke 0.16 2.95
Cancer, including lymphoma or leukemia 2.92 6.22
Alcohol/drug dependency 1.17 4.73
Manic depressive disorder 1.05 5.39
Anorexia/bulimia 0.11 1.97
Schizophrenia 0.52 2.58
* Fatigued includes subjects fatigued for at least one month
Table 3: Weighted prevalence (per 100,000 persons) of fatiguing illnesses nationally and by urban, rural, and regional location.
Location Prevalence (95% Confidence Interval)
Chronic Fatigue CFS-like Illness
Overall 12186 (9930–14870) 1197 (810–1770)
Urban 11480 (8780–14880) 1040 (600–1770)
Rural 14260 (11140–18080) 1670 (1030–2690)
Region
Northeast 12490 (8340–18300) 1900 (960–3750)
Midwest 14360 (9490–21160) 990 (430–2270)
South 11040 (7850–15310) 970 (470–1980)
West 11690 (6930–19040) 1160 (460–2900)Population Health Metrics 2004, 2 http://www.pophealthmetrics.com/content/2/1/1
Page 6 of 7
(page number not for citation purposes)
Previous investigations linking the distribution of fatigu-
ing illness according to race/ethnicity were not supported
in this study [1,2]. Similarly, we found no evidence for dif-
ferences in the prevalence of fatiguing illness by urban ver-
sus rural or by geographic region. However, in contrast to
previous studies, we found lower income and less educa-
tion to be the strongest predictive factors for fatiguing
illness.
These results are preliminary findings and must be inter-
preted conservatively. The primary objective of the pilot
study was to determine feasibility and test procedures for
a national survey of CFS. Thus we selected only one PSU
from each stratum, whereas a full-scale national survey
might involve a total of 100 or more PSUs. The selected
sample may not be large enough to detect various possible
demographic differences in CFS-like estimates. Also, per-
sons with CFS-like illness must undergo a clinical evalua-
tion to identify exclusionary medical and psychiatric
conditions and confirm classification as CFS. Clinical
evaluation proved difficult in terms of logistics and qual-
ity control. Only 7 of the 49 subjects with CFS-like illness
completed a clinical evaluation, and none had CFS.
Interpretation of the findings must also consider that
there are no diagnostic signs or laboratory abnormalities
so CFS is diagnostic solely on symptoms [3]. Symptom
criteria of the 1994 CFS research case definition are based
on self-report and there are no published standardized
and validated instruments that identify CFS in a manner
similar to the CIDI, DIS, or SCID for DSM-IV conditions
[4]. We obtained information to classify subjects as CFS-
like with an instrument designed by the CDC CFS
Research Group and used in previous CFS surveillance
studies. As noted, prevalence of CFS-like illness in the
national pilot study was similar to that in earlier CDC
studies that utilized the same instrument. We have also
used data from our most recent longitudinal surveillance
study [1] to perform exemplary analyses to validate the
instrument by comparing responses to the telephone sur-
vey questions with scores in the Multidimensional Fatigue
Inventory [5]. These analyses confirmed adequate validity
of the instrument [CDC unpublished].
Interpretation of the findings must also consider that CFS
is an exclusionary diagnosis based on symptoms for
which a medical or psychiatric explanation cannot be
found [3]. Subjects with exclusionary conditions reported
during the telephone interview were not classified as CFS-
like. However, to confirm diagnosis of CFS, persons who
meet symptom criteria on interview must be clinically
evaluated to identify medical or psychiatric conditions
not detected by interview. Just over 40 percent of subjects
with CFS-like illness detected in community surveys have
an exclusionary medical or psychiatric condition follow-
ing clinical evaluation [1,2].
Table 4: Weighted prevalence (per 100,000 persons) of fatiguing illnesses by demographic characteristics.
Characteristic Prevalence (95% Confidence Interval)
Chronic Fatigue CFS-like Illness
Sex
Male 9900 (7050–13750) 860 (420–1760)
Female 13810 (10620–17770) 1440 (900–2290)
Race
Non-white 7260* (4570–12440) 790 (270–2290)
White 13140 (10520–16290) 1280 (840–1950)
Age (yrs)
18–29 6440 (3540–11420) 1030 (350–2950)
30–39 8870 (5660–13620) 1120 (520–2390)
40–49 13310* (9060–19140) 1050 (540–2050)
50–59 16300* (11240–23040) 1630 (700–3750)
60–69 19590* (11790–30760) 1370 (420–4320)
Household income
≤ $40,000 17180* (12960–22410) 1470 (790–2750)
> $40,000 9990 (7120–13850) 920 (510–1650)
Educational level
≤ High school 17030* (12550–22710) 1650 (940–2880)
≥ College 8280 (6310–10790) 880 (500–1550)
* Difference between categories of characteristic is significant by survey-adjusted Wald test (P < .05)Publish with BioMed Central    and   every 
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Finally, interpretation of the findings must consider epi-
demiologic limitations in defining prevalence of an illness
such as CFS. This study attempted to estimate the point
prevalence of CFS-like illness (a surrogate for CFS). That is
the probability that an individual fulfilled case definition
criteria at the time of the survey. CFS presents a complex
and intermittent pattern of illness over time and persistent
CFS is the exception not the rule [6]. In population sur-
veys approximately 40 percent of persons with CFS-like
illness who are referred for clinical evaluation do not meet
all fatigue and symptom severity criteria of the case defini-
tion when evaluated clinically and thus cannot be consid-
ered prevalent cases [1,2]. Most of them likely represent
temporary remissions of the illness [6] but there are no
straightforward ways to consider this in prevalence
estimates.
Conclusions
In conclusion, this investigation suggests that 2.2 million
American adults between the ages of 18 and 69 years suf-
fer from CFS-like illness. We did not find evidence for
regional differences in the prevalence of fatiguing illnesses
but instead found that fatiguing illnesses are of overall
national importance. Most persons with CFS-like illness
found in this study had lower incomes and less education
than the non-fatigued population, suggesting social risk
factors (such as stress) may be important in the etiology of
CFS. This has important implications for public health
officials, health care providers, and the public in general.
The methodology and findings from this study should be
of interest to those studying CFS and with responsibilities
for health care in other countries.
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